Evidence map›Paper›PMID 41883561›Full record

ArticleClinical epidemiology2026

Timing of Core Sepsis Bundle Elements Initiation in Critically Ill Patients: A Multicenter Target Trial Emulation Study.

Mingxia Li, Jiaqi Zhang, Haozhao Huang, Jiamin Li, Buyao Zhang, Shuangping Zhao, Zishan Peng, Shuzhe Han, Jianbin Guan, Jingjing Yang and 6 more

Abstract read
In one paragraph

Article in Clinical epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mingxia Li *Department of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.ORCID 0000-0001-6567-6632
Jiaqi Zhang *Department of Internal Emergency Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Haozhao Huang *Department of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.ORCID 0009-0007-0779-1625
Jiamin Li *Department of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.ORCID 0009-0002-6741-1712
Buyao ZhangDepartment of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Shuangping ZhaoDepartment of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Zishan PengDepartment of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Shuzhe HanDepartment of Nutrition and Obstetrics and Gynecology, 967th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Dalian, Liaoning, People's Republic of China.
Jianbin GuanDepartment of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Jingjing YangDepartment of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Guizhong WangDepartment of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Yuan ChangDepartment of Gastrointestinal Electrophysiology, College of Medicine, Chosun University, Gwangju, Republic of Korea.
Ping ChangDepartment of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Zhaoxian YuState Key Laboratory of Respiratory Disease, Institute of Tuberculosis, Guangzhou Medical University and Guangzhou Chest Hospital Affiliated to Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.
Tao ZhongDepartment of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Zhanguo LiuDepartment of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.ORCID 0000-0002-7845-3080

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: One-hour sepsis bundle was developed in 2018. However, the optimal timing for antibiotic, fluid resuscitation, and vasopressor initiation in intensive care units (ICUs) remains debated. High-quality randomized evidence is limited, particularly for ICU patients. Therefore, we emulated three target trials using observational data. Patients and Methods: We conducted a retrospective, multicenter cohort study using data from the Medical Information Mart for Intensive Care-IV database (primary dataset), and two ICU cohorts from China (Zhujiang and Xiangya hospitals). Within a target trial emulation framework with inverse probability of treatment weighting, we constructed three two-arm trials comparing initiation of (1) antibiotics, (2) fluid resuscitation, and (3) vasopressors within 0-1 hour versus 1-3 hours after a prespecified time zero. Results: In the target trial emulations, antibiotic initiation within 1 hour was associated with lower 28-day mortality (HR 0.65; 95% CI 0.54-0.79) and earlier ICU discharge (competing-risk analysis; SHR 1.20; 95% CI 1.12-1.27) compared with initiation at 1-3 hours. For fluid resuscitation, initiating within 1 hour and delivering ≥30 mL/kg crystalloid within 3 hours resulted in lower mortality (HR 0.72; 95% CI 0.53-0.97) and earlier discharge (SHR 1.17; 95% CI 1.02-1.33). However, vasopressor initiation within 1 hour showed no survival benefit (HR 1.07; 95% CI 0.89-1.29) or reduction in time to ICU discharge (SHR 1.02; 95% CI 0.95-1.08). These findings remained consistent across sensitivity and subgroup analyses, including comparisons using a 1-6 hour window. Conclusion: In ICUs, early administration of antibiotics and initiation of fluid resuscitation within 1 hour were associated with improved survival and earlier ICU discharge, whereas early vasopressor use was not. These findings might support a bedside emphasis on timely antibiotics and fluids during early resuscitation and provide evidence for refining time targets in future sepsis guidelines.

Indexed as

antibioticfluid resuscitationsepsisseptic shockvasopressor

Identifiers

PMID41883561
PMCPMC13012147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.